Insider Transactions and Holdings
-
Entity Type
-
Company
-
Role
-
10%+ Owner
-
Issuer Symbol
-
TRML
There are no Buy or Sell transactions made by Clarus Defined Exit I, L.P. since 11 Mar 2025
Holdings reported by Clarus Defined Exit I, L.P. for Tourmaline Bio, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
160,044 |
$2,719,148 |
$16.99 |
11 May 2021 |
Indirect |
|
|
| Series A-1 Convertible Preferred Stock |
0 |
|
|
11 May 2021 |
Indirect |
Common Stock |
|
| Series A Convertible Preferred Stock |
0 |
|
|
11 May 2021 |
Indirect |
Common Stock |
|
| Series B Convertible Preferred Stock |
0 |
|
|
11 May 2021 |
Indirect |
Common Stock |
|
Transactions reported by Clarus Defined Exit I, L.P. for Tourmaline Bio, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.